Lubenau; Heinz

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lubenau; Heinz.The latest application filed is for "novel pd-l1 targeting dna vaccine for cancer immunotherapy".

Company Profile

3.16.21

Lubenau; Heinz - Neustadt an der Weinstrasse DE
Lubenau; Heinz - Neustadl an der Weinstrasse DE
Lubenau; Heinz - Neustadt DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel PD-L1 Targeting DNA Vaccine for Cancer Immunotherapy App 20220273782 - Lubenau; Heinz	2022-09-01
PD-L1 targeting DNA vaccine for cancer immunotherapy Grant 11,357,842 - Lubenau June 14, 2	2022-06-14
Process For The Production Of A Dna Vaccine For Cancer Immunotherapy App 20220072112 - Lubenau; Heinz	2022-03-10
Neoantigen Targeting Dna Vaccine For Combination Therapy App 20210213121 - Lubenau; Heinz	2021-07-15
VEGFR-2 targeting immunotherapy approach Grant 10,980,868 - Lubenau April 20, 2	2021-04-20
Vegfr-2 Targeting Dna Vaccine For Combination Therapy App 20210077605 - Lubenau; Heinz	2021-03-18
VEGFR-2 targeting DNA vaccine for combination therapy Grant 10,905,752 - Lubenau February 2, 2	2021-02-02
Process for the production of a DNA vaccine for cancer immunotherapy Grant 10,821,163 - Lubenau November 3, 2	2020-11-03
Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1 Grant 10,815,455 - Lubenau , et al. October 27, 2	2020-10-27
Novel Pd-l1 Targeting Dna Vaccine For Cancer Immunotherapy App 20200085928 - Lubenau; Heinz	2020-03-19
Novel Vegfr-2 Targeting Immunotherapy Approach App 20200038496 - Lubenau; Heinz	2020-02-06
MSLN targeting DNA vaccine for cancer immunotherapy Grant 10,441,645 - Springer , et al. Oc	2019-10-15
Process For The Production Of A Dna Vaccine For Cancer Immunotherapy App 20190183996 - Lubenau; Heinz	2019-06-20
DNA vaccine for use in pancreatic cancer patients Grant 10,293,037 - Lubenau	2019-05-21
Dna Vaccine For Use In Pancreatic Cancer Patients App 20190008936 - Lubenau; Heinz	2019-01-10
Vegfr-2 Targeting Dna Vaccine For Combination Therapy App 20180250345 - Lubenau; Heinz	2018-09-06
Salmonella-based Vectors For Cancer Immunotherapy Targeting Wilms' Tumor Gene Wt1 App 20180163169 - LUBENAU; Heinz ; et al.	2018-06-14
Novel Cmv Pp65 Targeting Dna Vaccine For Cancer Immunotherapy App 20180153976 - Lubenau; Heinz	2018-06-07
Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1 Grant 9,920,297 - Lubenau , et al. March 20, 2	2018-03-20
Novel Msln Targeting Dna Vaccine For Cancer Immunotherapy App 20180064794 - SPRINGER; Marco ; et al.	2018-03-08
Method for producing high yield attenuated Salmonella strains Grant 9,493,738 - Lubenau , et al. November 15, 2	2016-11-15
Novel Msln Targeting Dna Vaccine For Cancer Immunotherapy App 20160317634 - SPRINGER; Marco ; et al.	2016-11-03
Methods of preparing a liquid formulation of G-CSF Grant 9,468,685 - Hinderer , et al. October 18, 2	2016-10-18
Dna Vaccine For Use In Pancreatic Cancer Patients App 20160250311 - Lubenau; Heinz	2016-09-01
DNA vaccine for use in pancreatic cancer patients Grant 9,415,098 - Lubenau August 16, 2	2016-08-16
Salmonella-based Vectors For Cancer Immunotherapy Targeting Wilms' Tumor Gene Wt1 App 20160068801 - LUBENAU; Heinz ; et al.	2016-03-10
Dna Vaccine For Use In Pancreatic Cancer Patients App 20150165011 - Lubenau; Heinz	2015-06-18
Methods of treatment using glycopegylated G-CSF Grant 9,050,304 - Zopf , et al. June 9, 2	2015-06-09
Liquid Formulation Of G-csf App 20150125420 - Hinderer; Walter ; et al.	2015-05-07
Method of treatment using stable liquid formulation of G-CSF Grant 8,946,161 - Hinderer , et al. February 3, 2	2015-02-03
Method for Producing High Yield Attenuated Salmonella Strains App 20140349274 - Lubenau; Heinz ; et al.	2014-11-27
Liquid Formulation Of G-csf App 20140030214 - Hinderer; Walter ; et al.	2014-01-30
Stable liquid formulations of G-CSF Grant 8,562,967 - Hinderer , et al. October 22, 2	2013-10-22
Liquid Formulations Of G-csf App 20100216698 - Hinderer; Walter ; et al.	2010-08-26
Methods Of Treatment Using Glycopegylated G-csf App 20100120666 - Zopf; David A. ; et al.	2010-05-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.